The results shown in Figures 7A and 7B revealed that addition of Ang II significantly increased Erbb4-IR expression in CFs but not in cardiomyocytes in a time-dependent manner, suggesting a regulatory role of Erbb4-IR in CF-mediated cardiac fibrosis. Here, ERBB4 is linked to cystic fibrosis.